Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland

Cancer

Volumn 115, Issue 10, 2009, Pages 2128-2137

  Gomez, Daniel R ^a   Katabi, Nora ^a   Zhung, Joanne ^a   Wolden, Suzanne L ^a   Zelefsky, Michael J ^a   Kraus, Dennis H ^a   Shah, Jatin P ^a   Wong, Richard J ^a   Ghossein, Ronald A ^a   Lee, Nancy Y ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Acinic cell carcinoma; Histologic grading system; Parotid gland; Prognostic features; Radiation therapy; Salivary gland tumor

Indexed keywords

ACINAR CELL CARCINOMA; ADULT; ARTICLE; CANCER CENTER; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CLINICAL FEATURE; DERMATITIS; DISEASE FREE SURVIVAL; ESOPHAGITIS; FACIAL NERVE PARALYSIS; FEMALE; FOLLOW UP; GRAFT NECROSIS; HEARING DISORDER; HUMAN; HUMAN TISSUE; MALE; MUCOSA INFLAMMATION; OVERALL SURVIVAL; PAROTID GLAND CARCINOMA; PATHOLOGIST; POSTOPERATIVE CARE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT FAILURE; TRISMUS; UNIVARIATE ANALYSIS; VISUAL IMPAIRMENT; XEROSTOMIA;

ADULT; CARCINOMA, ACINAR CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FACIAL NERVE INJURIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PAROTID NEOPLASMS; PROGNOSIS;

EID: 65649121225     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24259     Document Type: Article

References (13)

1. Hoffman HT, Karnell LH, Robinson RA, Pinkston JA, Menck HR. National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma. Head Neck. 1999;21:297-309.
2. Carrillo JF, Vazquez R, Ramirez-Ortega MC, Cano A, Ochoa-Carrillo FJ, Onate-Ocana LF. Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland. Cancer. 2007;109:2043-2051.
3. Chen AM, Garcia J, Granchi PJ, Johnson J, Eisele DW. Late recurrence from salivary gland cancer: when does "cure" mean cure? Cancer. 2008;112:340-344.
4. Spafford PD, Mintz DR, Hay J. Acinic cell carcinoma of the parotid gland: review and management. J Otolaryngol. 1991;20:262-266.
5. Oliveira P, Fonseca I, Soares J. Acinic cell carcinoma of the salivary glands. A long term follow-up study of 15 cases. Eur J Surg Oncol. 1992;18:7-15.
6. Lewis JE, Olsen KD, Weiland LH. Acinic cell carcinoma. Clinicopathologic review. Cancer. 1991;67:172-179.
7. Ihrler S, Blasenbreu-Vogt S, Sendelhofert A, Lang S, Zietz C, Lohrs U. Differential diagnosis of salivary acinic cell carcinoma and adenocarcinoma (NOS). A comparison of (immuno-)histochemical markers. Pathol Res Pract. 2002;198:777-783.
8. Perzin KH, LiVolsi VA. Acinic cell carcinomas arising in salivary glands: a clinicopathologic study. Cancer. 1979;44:1434-1457.
9. Spiro RH, Huvos AG, Strong EW. Acinic cell carcinoma of salivary origin. A clinicopathologic study of 67 cases. Cancer. 1978;41:924-935.
10. Greene FL, Page DL, Fleming ID, et al, eds. American Joint Committee on Cancer Staging Handbook. 6th ed. New York: Springer; 2002.
11. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
12. Ellis GL, Corio RL. Acinic cell adenocarcinoma. A clinicopathologic analysis of 294 cases. Cancer. 1983;52:542-549.
13. Federspil PA, Constantinidis J, Karapantzos I, Pahl S, Markmann HU, Iro H. [Acinic cell carcinomas of the parotid gland. A retrospective analysis]. HNO. 2001;49:825-830.